Heat Biologics Net Income

Heat Biologics (HTBX) currently reports a net income of $-49T as of September 2025. That compares with $-36M in the prior-year period — down 135357742.6% year over year. That is below the Healthcare sector average of $16B. Use the charts on this page to explore Heat Biologics's net income history and peer comparisons.

Heat Biologics's net income decreased from $-36M to $-49T — a 135357742.6% year-over-year decrease (period ending September 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Heat Biologics's net income of $-49T is lower than the Healthcare sector average of $16B. That is roughly 294806.1% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Heat Biologics reported $-49T in net income as of September 2025. That compares with $-36M in the prior-year period — down 135357742.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net income of $-49T, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $16B. From there, open related valuation or income-statement pages for Heat Biologics, and consider following HTBX for alerts when major investors trade the stock.